There’s a wide gap between healthspan and lifespan. Hevolution Foundation was founded to fill it.
April 2024
Hevolution makes two additional impact invest- ments: Rubedo (to target pathologic senescent cells); and Tune (to sup- port creating epi-editing drugs that target com- plex chronic diseases).
June 2024
Hevolution reached a milestone of $400M+ in funding, grants, and investments , supporting research institutions to advance breakthroughs in aging science.
July 2024 Hevolution makes fourth impact invest- ment: Vandria SA (developing novel ther- apeutics that target mitophagy).
February 2025 Hevolution hosts 2nd GHS in Riyadh, world’s largest, convening nearly 3,500 global leaders from over 74 countries.
Made with FlippingBook - PDF hosting